Jasper Therapeutics Valuation
| JSPR Stock | USD 3.21 0.12 3.60% |
At this time, the firm appears to be undervalued. Jasper Therapeutics retains a regular Real Value of $14.9 per share. The prevalent price of the firm is $3.21. Our model calculates the value of Jasper Therapeutics from evaluating the firm fundamentals such as Return On Asset of -0.56, shares owned by insiders of 1.27 %, and Return On Equity of -1.01 as well as inspecting its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Jasper Therapeutics' valuation include:
Undervalued
Today
Please note that Jasper Therapeutics' price fluctuation is slightly risky at this time. Calculation of the real value of Jasper Therapeutics is based on 3 months time horizon. Increasing Jasper Therapeutics' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Jasper stock is determined by what a typical buyer is willing to pay for full or partial control of Jasper Therapeutics. Since Jasper Therapeutics is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Jasper Stock. However, Jasper Therapeutics' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 3.21 | Real 14.9 | Target 50.11 | Hype 3.21 | Naive 3.28 |
The intrinsic value of Jasper Therapeutics' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Jasper Therapeutics' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Jasper Therapeutics helps investors to forecast how Jasper stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Jasper Therapeutics more accurately as focusing exclusively on Jasper Therapeutics' fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Jasper Therapeutics' intrinsic value based on its ongoing forecasts of Jasper Therapeutics' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Jasper Therapeutics' closest peers.
Jasper Therapeutics Cash |
|
Jasper Valuation Trend
Jasper Therapeutics' real value is important for investors to make better decisions and a more accurate overall view of Jasper Therapeutics' financial worth over time. Using both Jasper Therapeutics' enterprise value as well as its market capitalization is the best way to gauge the value of the company and is usually enough for investors to make market timing conclusions.
Jasper Therapeutics Total Value Analysis
Jasper Therapeutics is currently projected to have valuation of 3.81 M with market capitalization of 50.02 M, debt of 1.81 M, and cash on hands of 60.81 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Jasper Therapeutics fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
3.81 M | 50.02 M | 1.81 M | 60.81 M |
Jasper Therapeutics Asset Utilization
One of the ways to look at asset utilization of Jasper is to check how much profit was generated for every dollar of assets it reports. Jasper Therapeutics retains a negative application of resources of -0.56 (percent), losing $0.00565 for each dollar of resources held by the firm. Inadequate asset utilization attests that the company is being less effective with each dollar of resources it retains. Simply put, asset utilization of Jasper Therapeutics shows how discouraging it operates for each dollar spent on its resources.Jasper Therapeutics Ownership Allocation
Jasper Therapeutics has a total of 15.02 Million outstanding shares. The majority of Jasper Therapeutics outstanding shares are owned by outside corporations. These institutional investors are usually referred to as non-private investors looking to purchase positions in Jasper Therapeutics to benefit from reduced commissions. Consequently, third-party entities are subject to a different set of regulations than regular investors in Jasper Therapeutics. Please pay attention to any change in the institutional holdings of Jasper Therapeutics as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.Jasper Therapeutics Profitability Analysis
Net Loss for the year was (71.27 M) with profit before overhead, payroll, taxes, and interest of 0.About Jasper Therapeutics Valuation
The stock valuation mechanism determines Jasper Therapeutics' current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Jasper Therapeutics based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Jasper Therapeutics. We calculate exposure to Jasper Therapeutics's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Jasper Therapeutics's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | -997.2 K | -1 M |
Jasper Therapeutics Growth Indicators
Investing in growth stocks can be very risky. If the company such as Jasper Therapeutics does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 14.6 M |
Jasper Therapeutics Current Valuation Indicators
Jasper Therapeutics' valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Jasper Therapeutics' valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Jasper Therapeutics, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Jasper Therapeutics' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Jasper Therapeutics' worth.Additional Tools for Jasper Stock Analysis
When running Jasper Therapeutics' price analysis, check to measure Jasper Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Jasper Therapeutics is operating at the current time. Most of Jasper Therapeutics' value examination focuses on studying past and present price action to predict the probability of Jasper Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Jasper Therapeutics' price. Additionally, you may evaluate how the addition of Jasper Therapeutics to your portfolios can decrease your overall portfolio volatility.